Dr. Jim Flatt Announced as New CEO of DMC Biotechnologies
DMC Biotechnologies, a leader in synthetic biology and precision fermentation, is pleased to announce the appointment of Dr. James (Jim) Flatt as Chief Executive Officer, effective immediately. Dr. Flatt brings…
Novo Nordisk Foundation establishes Biotechnology Research Institute for Green Transition (BRIGHT)
The Technical University of Denmark (DTU) has announced the establishment of a new initiative aimed at advancing bioproduction methods as part of efforts to transition away from fossil fuel reliance.…